HJGA
BSX icon

Hardman Johnston Global Advisors’s Boston Scientific BSX Stock Holding History

Hardman Johnston Global Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.19M Buy
168,360
+2,336
+1% +$127K 0.25% 46
2026
Q1 		$10.4M Sell
166,024
-62,240
-27% -$4.98M 0.49% 41
2025
Q4 		$21.8M Sell
228,264
-9,089
-4% -$891K 1.04% 30
2025
Q3 		$23.2M Buy
237,353
+3,849
+2% +$399K 1.14% 28
2025
Q2 		$25.1M Sell
233,504
-53,750
-19% -$5.44M 1.11% 29
2025
Q1 		$29M Sell
287,254
-39,650
-12% -$3.99M 1.38% 25
2024
Q4 		$29.2M Buy
326,904
+69,910
+27% +$6.15M 1.21% 29
2024
Q3 		$21.5M Sell
256,994
-97,550
-28% -$7.69M 0.84% 29
2024
Q2 		$27.3M Sell
354,544
-298,070
-46% -$21.8M 1.06% 29
2024
Q1 		$44.7M Sell
652,614
-22,326
-3% -$1.44M 1.54% 24
2023
Q4 		$39M Buy
674,940
+24,810
+4% +$1.32M 1.25% 27
2023
Q3 		$34.3M Sell
650,130
-94,390
-13% -$4.95M 1.15% 27
2023
Q2 		$40.3M Sell
744,520
-71,220
-9% -$3.72M 1.31% 27
2023
Q1 		$40.8M Sell
815,740
-3,500
-0.4% -$165K 1.33% 26
2022
Q4 		$37.9M Sell
819,240
-15,980
-2% -$692K 1.48% 24
2022
Q3 		$32.3M Buy
835,220
+201,720
+32% +$8.09M 1.46% 26
2022
Q2 		$23.6M Buy
633,500
+450
+0.1% +$18.3K 1% 35
2022
Q1 		$28M Sell
633,050
-168,370
-21% -$7.3M 0.9% 34
2021
Q4 		$34M Buy
801,420
+3,650
+0.5% +$153K 0.92% 30
2021
Q3 		$34.6M Sell
797,770
-4,750
-0.6% -$210K 0.93% 26
2021
Q2 		$34.3M Buy
802,520
+19,100
+2% +$804K 0.83% 28
2021
Q1 		$30.3M Buy
783,420
+171,790
+28% +$6.5M 0.86% 30
2020
Q4 		$22M Sell
611,630
-1,040
-0.2% -$37.5K 0.64% 39
2020
Q3 		$23.4M Buy
612,670
+81,160
+15% +$3.13M 0.88% 31
2020
Q2 		$18.7M Buy
531,510
+289,690
+120% +$10.4M 0.82% 39
2020
Q1 		$7.89M Buy
+241,820
New +$9.45M 0.46% 41

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hardman Johnston Global Advisors's BSX Position: Q2 2026 in Review

Hardman Johnston Global Advisors increased its Boston Scientific (BSX) stake by 1.4% in Q2 2026, buying an estimated $127K and bringing the position to 168,360 shares worth $7.19M. The position accounts for 0.25% of the portfolio, ranked #46.

Hardman Johnston Global Advisors first reported a position in BSX in Q1 2020 and has held it in 26 quarters since. The position peaked at $44.7M in Q1 2024. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Hardman Johnston Global Advisors held 168,360 shares of Boston Scientific worth $7.19M as of Q2 2026.
  • Hardman Johnston Global Advisors bought 2,336 Boston Scientific shares in Q2 2026, an estimated $127K.
  • Boston Scientific made up 0.25% of Hardman Johnston Global Advisors's portfolio in Q2 2026, its #46 holding.
  • Hardman Johnston Global Advisors first reported a position in Boston Scientific in Q1 2020 and has held it in 26 quarters since.
  • Hardman Johnston Global Advisors's Boston Scientific position peaked at $44.7M in Q1 2024.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Hardman Johnston Global Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.